Atlas Trials

Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients

Clinical trial NCT07067853 · COMPLETED

Trial details

NCT number
NCT07067853
Sponsor
Indonesia University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Migraine
Start date
2025-09-01
Primary completion
2025-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.